SBIR TOPIC283: DEVELOPMENT OF A MOLECULAR DIAGNOSTIC ASSAY TO DETECT BASAL-LIKE B
$995,819N44FY2013CANIH
Onconostic Technologies, Inc., Champaign IL
Investigators
Abstract
IN Vitro Diagnostic Test for Basal-Like Breast Cancer - A molecular diagnostic test based on detection of transcription factor FOXC1 at the protein and RNA level will be developed to accurately diagnose basal-like breast cancer (BLBC).
View original record on NIH RePORTER →